Tensegrity Pharma and argenx Collaborate on Innovative TSP-101 Research Tensegrity Pharma has entered into a collaboration with argenx for the research and development of TSP-101, targeting immune diseases.

Tensegrity Pharma and argenx Collaborate on Innovative TSP-101 Research #Japan #Tokyo #TSP-101 #Tensegrity_Pharma #argenx